Emv30null NOD-scid Mice: An Improved Host for Adoptive Transfer of Autoimmune Diabetes and Growth of Human Lymphohematopoietic Cells

When used as hosts in passive transfer experiments, a stock of NOD/Lt mice congenic for the severe combined immunodeficiency (scid) mutation have provided great insight to the contributions of various T-cell populations in the pathogenesis of autoimmune insulin-dependent diabetes mellitus (IDDM). Moreover, NOD-scid mice support higher levels of human lymphohematopoietic cell growth than the C.B-17-scid strain in which the mutation originated. However, the ability to perform long-term lymphohematopoietic repopulation studies in the NOD-scid stock has been limited by the fact that most of these mice develop lethal thymic lymphomas beginning at 20 weeks of age. These thymic lymphomas are characterized by activation and subsequent genomic reintegrations of Emv30, an endogenous murine ecotropic retrovirus unique to the NOD genome. To test the role of this endogenous retrovirus in thymomagenesis, we produced a stock of Emv30null NOD-scid mice by congenic replacement of the proximal end of chromosome 11 with genetic material derived from the closely related NOR/Lt strain. Thymic lymphomas still initiate in Emv30null NOD-scid females, but their rate of progression is significantly retarded since the frequency of tumors weighing between 170 and 910 mg at 25 weeks of age was reduced to 20.8% vs. 76.2% in Emv30% segregants. The thymic lymphomas that did develop in Emv30null NOD-scid mice were not characterized by a compensatory increase in mink cell focus–forming proviral integrations, which initiate thymomagenesis in other susceptible mouse strains. Significantly, the ability of standard NOD T-cells to transfer IDDM to the Emv30null NOD-scid stock was not impaired. Similarly, the elimination of Emv30 did notabrogate the enhanced ability of NOD-scid mice to support the growth of human peripheral blood leukocytes. These findings coupled with the slowed progression of thymic lymphomas indicate that Emv30null NOD-scid mice are an improved,but not yet optimal, recipient for long-term

[1]  D. Greiner,et al.  High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. , 1995, The Journal of infectious diseases.

[2]  D. Greiner,et al.  Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. , 1995, The American journal of pathology.

[3]  J. Dick,et al.  Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. , 1995, Human molecular genetics.

[4]  D. Greiner,et al.  Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. , 1995, Journal of immunology.

[5]  E. Leiter,et al.  Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene , 1994, The Journal of experimental medicine.

[6]  D. Longo,et al.  Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID). , 1994, Journal of immunology.

[7]  J. McCune,et al.  Human hematolymphoid cells in SCID mice. , 1994, Current opinion in immunology.

[8]  H. Gaskins,et al.  The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  V. Stewart,et al.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.

[10]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[11]  W. Frankel,et al.  NOR/Lt Mice: MHC-Matched Diabetes-Resistant Control Strain for NOD Mice , 1992, Diabetes.

[12]  K. Hamaguchi,et al.  NIT-1, a Pancreatic β-Cell Line Established From a Transgenic NOD/Lt Mouse , 1991, Diabetes.

[13]  J. Coffin,et al.  Virological events leading to spontaneous AKR thymomas , 1991, Journal of virology.

[14]  R. A. Phillips,et al.  The scid mutation in mice causes a general defect in DNA repair , 1990, Nature.

[15]  E. Leiter,et al.  Genetic Control of Diabetogenesis in NOD/Lt Mice: Development and Analysis of Congenic Stocks , 1989, Diabetes.

[16]  N. Copeland,et al.  Comparative molecular genetic analysis of lymphomas from six inbred mouse strains , 1988, Journal of virology.

[17]  I. Weiler,et al.  Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency , 1986, Cell.

[18]  M. Martin,et al.  Specific hybridization probes demonstrate fewer xenotropic than mink cell focus-forming murine leukemia virus env-related sequences in DNAs from inbred laboratory mice , 1986, Journal of virology.

[19]  R. Custer,et al.  Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. , 1985, The American journal of pathology.

[20]  D. Steinmuller.  Adoptive transfer. , 1984, Methods in enzymology.

[21]  R. Custer,et al.  A severe combined immunodeficiency mutation in the mouse , 1983, Nature.